DrugsControl Media Services

News Detail

Indian pharma sees ICH Q12 for FDA-regulated products to help ascertain product quality risk (18-09-2021)

Bengaluru, 18 Sept 2021: Indian pharma industry sees that the International Council for Harmonisation (ICH) guidance for industry on Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management provides a framework to expedite the management of post......
View Details

Source : Pharmabiz

Related News